CD44 is involved in cancer progression, metastasis, and resistance to treatment (Guo et al. 2021), and the expression of CD44s is upregulated in human pancreatic cancer cell lines and in tumorous tissue samples from patients with pancreatic adenocarcinoma (Li et al. 2014; Wood. This evidence concerns the gene CD44 and familial pancreatic carcinoma.